How should I manage a 24-year-old female with resolved epigastric pain who was started on omeprazole (a proton pump inhibitor) for possible gastritis or gastric ulcer at her new primary care visit?

Management of 24-Year-Old Female with Resolved Epigastric Pain on Omeprazole

You should test for Helicobacter pylori infection now and plan to discontinue the PPI after completing a short 4-8 week course, as this young patient without alarm features does not require long-term acid suppression for presumed gastritis. 1

Immediate Actions

Test for H. pylori

• Perform H. pylori testing with either a urea breath test or stool antigen test (these are the optimal non-invasive methods). 1
• If positive, treat with eradication therapy: the preferred regimen is bismuth quadruple therapy for 14 days, or alternatively rifabutin triple therapy for 14 days. 2
• If H. pylori is eradicated, this addresses the underlying cause and reduces future gastric cancer risk. 1

Assess for Alarm Features

• Confirm absence of alarm features that would mandate endoscopy: weight loss, dysphagia, persistent vomiting, evidence of GI bleeding, or family history of gastric cancer. 1, 3
• At age 24, she is well below the 55-year threshold where empiric endoscopy would be considered. 1

PPI Management Plan

Duration of Therapy

• Complete the 30-day omeprazole course as prescribed (consistent with FDA-approved 4-8 week treatment for gastritis/ulcer). 3
• The FDA label supports short-term treatment (4-8 weeks) for active gastric ulcer and symptomatic GERD. 3
• Do not continue PPI beyond 4-8 weeks without a documented indication, as prolonged use increases risks of C. difficile infection, bone fractures, hypomagnesemia, vitamin B12 deficiency, and acute interstitial nephritis. 3

Discontinuation Strategy

• Either abrupt discontinuation or dose tapering are acceptable when stopping the PPI—there is no significant difference in success rates between these approaches. 1
• Warn the patient about rebound acid hypersecretion (RAHS), which can cause temporary upper GI symptoms for up to 2 months after stopping PPIs, even in patients who never had acid-related disease. 1
• Provide as-needed H2-receptor antagonists (like famotidine) or antacids to manage any post-discontinuation symptoms without committing to continuous PPI therapy. 1
• Severe persistent symptoms lasting more than 2 months after discontinuation may indicate a true ongoing indication for acid suppression. 1

Follow-Up Plan

Test-of-Cure if H. pylori Positive

• Perform post-treatment test-of-cure at least 4 weeks after completing eradication therapy (and at least 2 weeks off PPI) using urea breath test or stool antigen. 2

Symptom Monitoring

• If symptoms recur after PPI discontinuation and persist beyond 2 months despite as-needed antacids/H2-blockers, consider endoscopy to evaluate for peptic ulcer disease or other pathology. 1
• Endoscopy is generally not indicated in young patients without alarm features who respond to initial therapy, as the probability of finding significant organic disease is very low. 1

Key Pitfalls to Avoid

• Do not continue PPI indefinitely without reassessment—this 24-year-old does not have a documented indication for long-term therapy (such as Barrett's esophagus, severe erosive esophagitis, or high-risk conditions requiring gastroprotection). 1, 3
• Do not assume symptom response to PPI confirms the diagnosis—in older patients, symptomatic response does not exclude gastric malignancy, though this is less relevant at age 24. 3
• Do not skip H. pylori testing—eradication prevents future ulcer complications and reduces gastric cancer risk. 1, 2
• Do not restart continuous PPI for transient symptoms immediately after discontinuation—these may represent RAHS rather than true disease. 1